Trialant
Platform
Home
Studies
Other
Contact Us
Terms of Service
Privacy Policy
Toggle Sidebar
Studies
Study
JSON
Overview
Key facts that identify this study and show where it stands today.
Description
What the study is about and why it is being run, in the researchers' own words.
Conditions
The medical conditions and diseases this study investigates.
Interventions
The treatments and procedures being evaluated in this study.
Participation
Who can join this study and the criteria used to decide.
Design
How the study is designed and how its participant groups are organized.
Contacts
The people to reach with questions about this study or how to join it.
Locations
Where the study is run and whether each site is currently recruiting.
Collaborators
The organizations and people involved in this study.
Similar Studies
Other registered studies that closely resemble this one.
Workspace
Home
Studies
Collections
Views
Contact Us
Terms of Service
Privacy Policy
Sign up
NCT00141882
Memantine in Patients With Chronic Glaucoma
NCT00168350
Completed
Interventional
Phase 3
Updated Nov 4, 2010
Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma
NCT04499157
Terminated
Interventional
Not Applicable
Updated Jun 12, 2026
Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)
NCT00414206
Terminated
Interventional
Phase 2
Updated Nov 23, 2010
Early Manifest Glaucoma Trial (EMGT)
NCT00000132
Unknown status
Interventional
Phase 3
Updated Jun 24, 2005
A Multi-Dose Study With a Treatment for Open-Angle Glaucoma
NCT00705770
Withdrawn
Interventional
Phase 2
Phase 3
Updated May 30, 2012
A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma
NCT05160805
Completed
Interventional
Phase 1
Updated Oct 29, 2024
Memantine in Patients With Chronic Glaucoma | NCT00141882 | Trialant
Save
Share
Completed
Interventional
Phase 3
Updated Nov 4, 2010
Memantine in Patients With Chronic Glaucoma
ClinicalTrials.gov ID
NCT00141882
Lead Sponsor
Allergan
INDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 3
Enrollment
1,119
Actual
Last Update Posted
Nov 4, 2010
Estimated
Start Date
Mar 1999
Primary Completion Date
Jan 2006
Actual
Completion Date
Aug 2006
Actual
Brief Summary
Randomized double-masked clinical trial of memantine in patients with glaucoma
Open-Angle Glaucoma
memantine
Ages Eligible for Study
Adult (18-64)
Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Glaucoma damage on examination of visual field and optic disc
Good visual acuity (with glasses if needed)
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Double
No central contacts
There are no central contacts for this study.
No locations
There are no locations for this study.
Lead Sponsor
Allergan
INDUSTRY